A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2004
12/08/2004	CN1178688C Health-care food for resisting fatigue
12/08/2004	CN1178675C Toxin-dischargin liver-fortifying medicine
12/08/2004	CN1178668C Use of Chinese angelica polysaccharide in oral colon orientation releasing pro-drug
12/08/2004	CN1178656C Pharmaceutical composition
12/08/2004	CN1178648C Use of H+, K+-ATPase inhibitors in preparing oral medicine for enhancing inhibition of gastric acid secretion
12/08/2004	CN1178592C Drinks and foods capable of eliminating helicobacter pylori
12/08/2004	CN1178587C Ginseng flower health tea and its producing process
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828345 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828301 Pharmaceutical compositions for hepatitis C viral protease inhibitors
12/07/2004	US6828298 Glycoprotein having inhibitory activity against helicobacter pylori colonization
12/07/2004	US6827945 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004104575A2 Diagnostics and therapeutics for diseases associated with x-prolyl aminopeptidase 2 (xpnpep2)
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103972A1 Novel piperidine derivative
12/02/2004	WO2004103403A1 Immunocompetent cell activation inhibitor and use thereof
12/02/2004	WO2004103391A1 Hepatic lipid metabolism accelerating agent, hepatic lipid metabolism accelerating health food and process for producing peptide mixture as active ingredient thereof
12/02/2004	WO2004103371A1 Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea
12/02/2004	WO2004103083A1 A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242890 Agonists of beta-adrenoceptors
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242657 Reaction of a phenoxypropionic acid compound with a trifluoromethylphenylthiazole compound; for manufacture of a medicament for treatment of a human peroxisome proliferator activated receptor alpha mediated disease or condition such as hypercholesteremia, cardiovascular disease
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242651 to gastrointestal systems, kidneys
12/02/2004	US20040242642 Crystalline esomeprazole compounds and process for the preparation thereof
12/02/2004	US20040242636 Enzyme inhibitors as antiinflammatory ageents for psoriasis, obesity
12/02/2004	US20040242632 Method for treating inflammatory bowel disease
12/02/2004	US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242621 Method of treating hepatic fibrosis
12/02/2004	US20040242597 Combination
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
12/02/2004	US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004	US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin
12/02/2004	US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
12/02/2004	US20040241840 Compositions for therapy
12/02/2004	US20040241815 Process for producing 1,4-dihysdroxy-2-naphthoic acid
12/02/2004	US20040241803 25 human secreted proteins
12/02/2004	US20040241772 Solid composition cantaining bacillus-type non-pathogenic bacterial spores
12/02/2004	US20040241705 Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi
12/02/2004	US20040241257 Animal food supplement compositions and methods of use
12/02/2004	US20040241204 Sustained release pharmaceutical composition
12/02/2004	US20040241184 Fermentation product of cyptoporous volvatus and its preparation method and use
12/02/2004	US20040241138 Methods of treating liver fibrosis
12/02/2004	DE10061195B4 Verwendung von Abformmassen zur Herstellung von Behandlungsvorrichtungen Use of impression materials for the production of treatment devices
12/02/2004	CA2526374A1 2-aminoquinoline derivatives
12/02/2004	CA2526158A1 A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survivalproperty, intestinal binding property, an infection protection property and a fiber fermenting property
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481969A1 Piperidine derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004	EP1481687A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
12/01/2004	EP1481686A1 Use of multimeric ligands of the TNF family with reduced toxicity for treating cell proliferative diseases
12/01/2004	EP1481684A1 Remedies for liver diseases, hyperlipemia and diabetes
12/01/2004	EP1481682A1 Preparation that contains oligosaccharides and probiotics
12/01/2004	EP1481672A1 Compositions for ameliorating fecal properties
12/01/2004	EP1481077A2 Mitotic kinesin inhibitors
12/01/2004	EP1481000A2 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
12/01/2004	EP1480974A1 Heterocyclylmethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors
12/01/2004	EP1480973A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
12/01/2004	EP1480972A2 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
12/01/2004	EP1480962A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
12/01/2004	EP1480959A1 Piperazine derivatives as anti-inflammatory agents
12/01/2004	EP1480954A1 Vanilloid receptor modulators
12/01/2004	EP1480688A1 N-(5- 4-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine coated stents
12/01/2004	EP1480670A2 Cg3842 homologous proteins involved in the regulation of energy homeostasis
12/01/2004	EP1480647A1 Mono-ester and asymmetrically substituted di-ester pro-drugs of the dopamine d1 receptor agonists
12/01/2004	EP1480626A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
12/01/2004	EP1480598A2 Manipulation of cytokine levels using cd83 gene products
12/01/2004	EP1358180B1 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1317188B1 Use of benzophenanthridine alkaloids as feed additives
12/01/2004	EP1214093B1 Method for producing a tablet made of isomaltulose, isomalt or isomalt variants and corresponding products
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1139784B1 Food-induced antisecretory proteins in egg yolk
12/01/2004	EP1119538B1 Derivatives of phenantrene for medicinal use and a process for their preparation
12/01/2004	EP1117388A4 Antioxidant gel for gingival conditions
12/01/2004	EP1059943B1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551914A FAD4, FAD5, FAD5-2 and FAD6, novel fatty acid desaturase family members and uses thereof
12/01/2004	CN1551871A Process for preparinga thiazole PPAR-ligand and polymorphs thereof
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

1 ... 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 ... 1258